Skip to content
ATTOAttovia Therapeutics, Inc.

Earnings

When Attovia Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.

6 quarters. Mar 31, 2025 to Sep 30, 2026. USD.

Quarter by quarter

Q3 2026$0.00−100.0% vs Q3 2025

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 9, 2026 · after-hoursNov 9, 202640 d10-Q$0.00−100.0%-$0.76+4.2%
Q2 2026Jun 30, 2026Sep 2, 2026 · after-hoursSep 2, 202664 d10-Q$450.00K—-$4.88+4.7%
Q1 2026Mar 31, 2026————————
FY 2025
Q3 2025Sep 30, 2025————$360.00K—-$3.44—
Q2 2025Jun 30, 2025————$0.00—-$3.71—
Q1 2025Mar 31, 2025————————

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 9, 2026453622
10-QSep 2, 2026380228

Provenance

ProvenanceData status and checks

Attovia Therapeutics, Inc. · CIK 2058707 · Engraved from SEC EDGAR